Anna Mizutani

819 total citations
21 papers, 549 citations indexed

About

Anna Mizutani is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Anna Mizutani has authored 21 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Anna Mizutani's work include Cancer-related gene regulation (6 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and TGF-β signaling in diseases (3 papers). Anna Mizutani is often cited by papers focused on Cancer-related gene regulation (6 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and TGF-β signaling in diseases (3 papers). Anna Mizutani collaborates with scholars based in Japan, United States and Sweden. Anna Mizutani's co-authors include Kohei Miyazono, Daizo Koinuma, Hiroyuki Seimiya, Masato Morikawa, Hiroyuki Aburatani, Haruka Yoshida, Shuichi Tsutsumi, Yukiko Muramatsu, Natsumi Kawasaki and Yusuke Tamura and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Anna Mizutani

21 papers receiving 546 citations

Peers

Anna Mizutani

ONCOL

IMMUN

PFM

Xin‐Zhe Li China

Rosa Pasquinelli Italy

Daniele Conti Italy

Ka Ho Tam Hong Kong

Yu-Ting Su Taiwan

Jihui Qiu United States

Jialing Zhong China

Monika Buríková Slovakia

Roi Villar-Vázquez Spain

Xin‐Zhe Li China

Anna Mizutani

356 ×0.9

95 ×0.6

ONCOL

95 ×0.9

53 ×1.1

IMMUN

40 ×1.0

PFM

Citations per year, relative to Anna Mizutani Anna Mizutani (= 1×) peers Xin‐Zhe Li

Countries citing papers authored by Anna Mizutani

Since Specialization

Citations

This map shows the geographic impact of Anna Mizutani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Mizutani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Mizutani more than expected).

Fields of papers citing papers by Anna Mizutani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Mizutani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Mizutani. The network helps show where Anna Mizutani may publish in the future.

Co-authorship network of co-authors of Anna Mizutani

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Mizutani. A scholar is included among the top collaborators of Anna Mizutani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Mizutani. Anna Mizutani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mizutani, Anna & Hiroyuki Seimiya. (2019). Tankyrase promotes primary precursor miRNA processing to precursor miRNA. Biochemical and Biophysical Research Communications. 522(4). 945–951. 3 indexed citations

Mizutani, Anna, et al.. (2018). CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development. Oncogene. 38(14). 2580–2594. 14 indexed citations

Mizutani, Anna, Yoko Yashiroda, Yukiko Muramatsu, et al.. (2018). RK‐287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model. Cancer Science. 109(12). 4003–4014. 58 indexed citations

Tanaka, Noritaka, Tetsuo Mashima, Anna Mizutani, et al.. (2017). APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer. Molecular Cancer Therapeutics. 16(4). 752–762. 68 indexed citations

Tamura, Yusuke, Natsumi Kawasaki, Kazunobu Isogaya, et al.. (2017). Dynamics of chromatin accessibility during TGF-β-induced EMT of Ras-transformed mammary gland epithelial cells. Scientific Reports. 7(1). 1166–1166. 23 indexed citations

Mashima, Tetsuo, Anna Mizutani, Yukiko Muramatsu, et al.. (2017). mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer. Oncotarget. 8(29). 47902–47915. 19 indexed citations

Katsura, Akihiro, Yusuke Tamura, Satoshi Hokari, et al.. (2017). ZEB1‐regulated inflammatory phenotype in breast cancer cells. Molecular Oncology. 11(9). 1241–1262. 88 indexed citations

Morikawa, Masato, Daizo Koinuma, Anna Mizutani, et al.. (2016). BMP Sustains Embryonic Stem Cell Self-Renewal through Distinct Functions of Different Krüppel-like Factors. Stem Cell Reports. 6(1). 64–73. 53 indexed citations

Suhard, Samuel, et al.. (2016). Integrated clean for TSV: Comparison between dry process and wet processes and their electrical qualification. 441–444. 2 indexed citations

10.

Vasilaki, Eleftheria, Masato Morikawa, Daizo Koinuma, et al.. (2016). Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program. Science Signaling. 9(442). ra84–ra84. 35 indexed citations

11.

Mizutani, Anna, Daizo Koinuma, Hiroyuki Seimiya, & Kohei Miyazono. (2015). The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma. Oncogene. 35(27). 3514–3523. 39 indexed citations

12.

Mizutani, Anna, Daizo Koinuma, Hiroyuki Seimiya, & Kohei Miyazono. (2015). Abstract 2131: The Arkadia-ESRP2 axis suppresses tumor progression: Analyses in clear cell renal cell carcinoma. Cancer Research. 75(15_Supplement). 2131–2131. 1 indexed citations

13.

Ishikawa, Hidehiro, Natsuko Kawada, Akira Taniguchi, et al.. (2015). Paraneoplastic neurological syndrome due to burned-out testicular tumor showing hot cross-bun sign. Acta Neurologica Scandinavica. 133(5). 398–402. 18 indexed citations

14.

Minegishi, Yuriko, Yoshio Shibagaki, Anna Mizutani, et al.. (2012). Adaptor protein complex of FRS2β and CIN85/CD2AP provides a novel mechanism for ErbB2/HER2 protein downregulation. Cancer Science. 104(3). 345–352. 6 indexed citations

15.

Mizutani, Anna, Daizo Koinuma, Shuichi Tsutsumi, et al.. (2011). Cell Type-specific Target Selection by Combinatorial Binding of Smad2/3 Proteins and Hepatocyte Nuclear Factor 4α in HepG2 Cells. Journal of Biological Chemistry. 286(34). 29848–29860. 40 indexed citations

16.

Mizutani, Anna, Masao Saitoh, Takeshi Imamura, Keiji Miyazawa, & Kohei Miyazono. (2010). Arkadia complexes with clathrin adaptor AP2 and regulates EGF signalling. The Journal of Biochemistry. 148(6). 733–741. 13 indexed citations

17.

Ishida, Y., Anna Mizutani, Kenkichi Sugiura, Hiromichi Ohta, & Kunihito Koumoto. (2010). Metal-nonmetal transition inLixCoO2thin films and thermopower enhancement at high Li concentration. Physical Review B. 82(7). 10 indexed citations

18.

Mizutani, Anna, et al.. (2007). Involvement of 101F6, a Homologue of Cytochrome b561, in the Reduction of Ferric Ions. The Journal of Biochemistry. 142(6). 699–705. 18 indexed citations

19.

Mizutani, Anna. (2003). Regions of GAL4 critical for binding to a promoter in vivo revealed by a visual DNA-binding analysis. The EMBO Journal. 22(9). 2178–2187. 12 indexed citations

20.

Katayama, Masayuki, et al.. (1998). Gallium‐rich CaGa^αS^β:Ce as a new blue electroluminescent phosphor. Journal of the Society for Information Display. 6(1). 5–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact